BLMH:OTC-Blum Holdings Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 1.1

Change

+0.09 (+8.91)%

Market Cap

USD 0.01B

Volume

4.30K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Blum Holdings, Inc. cultivates, manufactures, distributes, and retails medical and adult use cannabis products in California. The company operates through Cannabis Retail and Cannabis Distribution segments. It also manages medical marijuana retail and adult use dispensaries, cultivation, and manufacturing facilities. The company was formerly known as Unrivaled Brands, Inc. and changed its name to Blum Holdings, Inc. in January 2024. Blum Holdings, Inc. was founded in 2010 and is headquartered in Santa Ana, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
JDHIY JD Health International Inc

N/A

USD 12.19B
JDHIF JD Health International Inc

N/A

USD 10.00B
ALBHF Alibaba Health Information Tec..

N/A

USD 7.93B
RADLY Raia Drogasil SA ADR

-0.15 (-4.27%)

USD 6.15B
CLCGY Clicks Group Ltd

-0.30 (-0.78%)

USD 4.66B
SHPPF Shop Apotheke Europe N.V

N/A

USD 2.58B
SAEYY Shop Apotheke Europe N.V

N/A

USD 2.47B
NOTR Nowtransit Inc

N/A

USD 0.55B
ZRSEF Zur Rose Group AG

N/A

USD 0.26B
PNPL Pineapple Express

N/A

USD 7.31M

ETFs Containing BLMH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 144.44% 100% F 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 144.44% 100% F 96% N/A
Trailing 12 Months  
Capital Gain 34.15% 89% A- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.15% 89% A- 77% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.40% 36% F 39% F
Dividend Return 0.40% 36% F 35% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.34% 100% F 99% N/A
Risk Adjusted Return 9.21% 48% F 42% F
Market Capitalization 0.01B 55% F 39% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.